Overview
Spondyloepiphyseal dysplasia congenita (SEDC) is a rare genetic disorder that affects bone growth and development. It is caused by heterozygous pathogenic variants in the COL2A1 gene, leading to short‑trunk stature, kyphoscoliosis, and a predisposition to respiratory compromise because of a narrow thoracic cage. Women with SEDC who become pregnant face a unique set of challenges: the expanding uterus further restricts an already limited chest volume, and the increased metabolic demands of pregnancy can unmask or worsen hypoxemia. The case described in this report demonstrates that, with meticulous respiratory surveillance and a coordinated multidisciplinary team, a pregnancy can be carried to term while maintaining maternal and fetal safety.
In plain language, this means that even though SEDC makes pregnancy more difficult, careful planning, regular monitoring, and early intervention can allow a woman with this condition to have a healthy baby and recover well after delivery.
What This Study Examined
This case report and literature review examined the pregnancy outcomes in women with SEDC, with a focus on respiratory management, fetal monitoring, and perinatal decision‑making. The authors aimed to demonstrate the feasibility of expectant management to term in women with SEDC, despite the associated risks and complications.
Why This Matters for Patients
For patients with SEDC, this study provides valuable insights into the management of pregnancy and the anticipation of potential complications. It highlights the importance of close monitoring and collaboration between obstetricians, orthopedic specialists, pulmonologists, anesthesiologists, and neonatologists to ensure the best possible outcomes for both mother and baby.
Medical Background
Spondyloepiphyseal dysplasia congenita is a rare skeletal dysplasia that affects the development of bones and cartilage. It is characterized by short‑trunk stature, kyphoscoliosis, and respiratory compromise due to a narrow chest cavity. The condition is caused by mutations in the COL2A1 gene, which codes for a protein essential for the development of cartilage and bone.
Beyond the orthopedic manifestations, individuals with SEDC often experience early‑onset myopia, hearing loss, and a heightened risk of spinal stenosis. In the obstetric context, the reduced functional residual capacity of the lungs can lead to nocturnal desaturation, especially in the third trimester when diaphragmatic excursion is limited by the gravid uterus.
How the Procedure Works
In the context of SEDC, pregnancy management involves close monitoring of the mother's respiratory status and fetal well‑being. This may include regular ultrasound examinations, cardiotocography, and pulse oximetry to monitor oxygen saturation levels. In some cases, oxygen therapy may be necessary to maintain adequate oxygenation.
Who Is a Candidate?
Women with SEDC who become pregnant are candidates for close monitoring and multidisciplinary management. This includes collaboration between obstetricians, orthopedic specialists, pulmonologists, anesthesiologists, and neonatologists to ensure the best possible outcomes for both mother and baby.
Clinical Summary
- Procedure: Pregnancy management in women with SEDC
- Typical Duration: Throughout pregnancy, with close monitoring from 28–32 weeks gestation
- Recovery: Post‑partum recovery is similar to that of women without SEDC, although close monitoring of respiratory status may be necessary
- Success Rate (general): High success rate with careful planning and multidisciplinary management, although individual outcomes may vary
Study Methodology
The study reported a case of a 30‑year‑old primigravida with SEDC who underwent close monitoring and multidisciplinary management during pregnancy. The patient was admitted to the hospital at 33 weeks gestation for respiratory monitoring and underwent regular ultrasound examinations and cardiotocography to monitor fetal well‑being.
Patient Selection Criteria
The patient was selected for the study based on her confirmed diagnosis of SEDC (heterozygous COL2A1 pathogenic variant) and her desire to pursue a full‑term pregnancy. She had no other significant comorbidities, and her pre‑pregnancy pulmonary function tests showed a forced vital capacity (FVC) of 62 % predicted, which is typical for SEDC.
Outcome Measures
The primary outcomes were maternal respiratory stability (oxygen saturation ≥ 94 % on room air or low‑flow supplemental oxygen), gestational age at delivery, and neonatal health indicators (Apgar score, need for ventilatory support, radiographic confirmation of SEDC). Secondary outcomes included maternal quality‑of‑life scores, length of hospital stay, and any peri‑operative complications.
Monitoring Protocol
- Daily nocturnal pulse oximetry from 30 weeks onward.
- Twice‑weekly fetal biophysical profile (BPP) and growth ultrasounds.
- Weekly multidisciplinary team meetings involving obstetrics, pulmonology, orthopedics, anesthesiology, and neonatology.
- Low‑flow oxygen (1 L/min) initiated when night‑time SpO₂ fell below 92 %.
- Elective cesarean delivery planned at 37 weeks for cephalopelvic disproportion based on pelvic measurements.
Results & Findings
Maternal Respiratory Course: At 33 weeks, baseline SpO₂ on room air was 96 %. By 34 weeks, nocturnal desaturation episodes to 91 % were documented. After exclusion of pulmonary embolism (CT pulmonary angiography negative) and cardiac dysfunction (echocardiogram normal EF 62 %), low‑flow nocturnal oxygen supplementation was started. With 1 L/min O₂, overnight SpO₂ remained >96 % for the remainder of the pregnancy. No episodes of daytime hypoxemia or respiratory failure occurred, and the patient reported only mild fatigue.
Fetal Findings: Serial ultrasounds revealed a small thoracic circumference consistent with SEDC, and at 32 weeks a short femur length (−2.3 SD) was noted. The fetal biophysical profile scores were consistently 8–10/10. No hydrops or polyhydramnios developed.
Delivery Details: An elective cesarean section was performed at 37 weeks and 2 days gestation. The indication was cephalopelvic disproportion, confirmed by MRI‑pelvic measurements (anteroposterior diameter 9.8 cm). A male infant weighing 2600 g was delivered. Apgar scores were 8 at 1 minute and 9 at 5 minutes.
Neonatal Course: The neonate required brief (≈12 hours) non‑invasive ventilation for mild respiratory distress related to a small thoracic cage. Radiographs confirmed features of SEDC (short ribs, platyspondyly). Genetic testing later corroborated the inheritance of the familial COL2A1 variant. The infant was discharged home on day 7 with normal feeding and no neurologic deficits.
Follow‑up: At 6‑month post‑partum, the mother’s pulmonary function remained stable (FVC 61 % predicted) and she reported a return to baseline activity levels. The baby continued to grow along the expected curve for SEDC, with orthopedic follow‑up planned for early childhood.
Overall, the case demonstrates that a carefully titrated oxygen regimen, frequent respiratory monitoring, and a pre‑planned delivery strategy can permit a term pregnancy in women with SEDC without maternal or fetal morbidity.
Clinical Implications
The successful outcome of this case has several practical implications for clinicians caring for pregnant patients with SEDC or other collagen‑type II disorders:
- Pre‑conception counseling: Genetic counseling should address the 50 % transmission risk of COL2A1 variants and discuss expected skeletal findings in the fetus.
- Respiratory surveillance: Nocturnal pulse oximetry should be initiated by the end of the second trimester. A threshold of SpO₂ < 92 % warrants low‑flow supplemental oxygen, which in this series was sufficient to maintain safe levels.
- Multidisciplinary care: Regular case conferences that include obstetrics, pulmonology, orthopedics, anesthesiology, and neonatology enable rapid decision‑making regarding timing of delivery and anesthesia planning.
- Delivery planning: Pelvic imaging (MRI or 3‑D ultrasound) can identify cephalopelvic disproportion early, allowing for elective cesarean delivery at 37 weeks, which balances the risks of prematurity with maternal respiratory decompensation.
- Neonatal preparation: Anticipating a small thoracic cage prompts readiness for brief ventilatory support and early orthopedic assessment.
Importantly, these strategies are not limited to SEDC; they may be extrapolated to other skeletal dysplasias that compromise thoracic volume, such as achondrogenesis or thanatophoric dysplasia, where maternal respiratory endurance is a pivotal factor.
Frequently Asked Questions
- Q: Can a woman with SEDC become pregnant without any extra monitoring?
- A: While pregnancy is possible, most experts recommend pre‑conception counseling and close respiratory surveillance during the third trimester because the growing uterus can further limit chest expansion and cause nocturnal desaturation.
- Q: What is the typical gestational age for delivery in SEDC patients?
- A: There is no single guideline, but many reports suggest aiming for 37–38 weeks if maternal respiratory status remains stable; earlier delivery may be needed if hypoxemia or cardiac strain develops.
- Q: Is supplemental oxygen safe for the fetus?
- A: Low‑flow oxygen (1–2 L/min) is considered safe and may improve fetal oxygen delivery; it does not increase risk of congenital anomalies.
- Q: Will the baby definitely inherit SEDC?
- A: There is a 50 % chance of inheriting the pathogenic COL2A1 variant. In this case, fetal ultrasound findings and post‑natal imaging strongly suggested inheritance, which was confirmed by genetic testing.
- Q: What long‑term outcomes can be expected for a child born with SEDC?
- A: Children with SEDC typically have short stature, early‑onset myopia, and may develop spinal stenosis or joint problems. With early orthopedic monitoring and appropriate interventions, many achieve functional independence and a good quality of life.